Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-I
暂无分享，去创建一个
J. Dipersio | M. Arcasoy | H. Kantarjian | S. Verstovsek | M. Deininger | R. Paquette | R. Mesa | M. Talpaz | R. Silver | A. Raza | Carole B. Miller | J. Gotlib | Vikas Gupta | K. Vaddi | E. Hexner | R. Levy | J. Catalano | R. Lyons | E. Winton | J. Harvey | William Sun | V. Sandor | S. Erickson‐Viitanen